Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Low Cylinder Toric

This study has been completed.
Sponsor:
Information provided by:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00732030
First received: August 7, 2008
Last updated: March 25, 2010
Last verified: March 2010

August 7, 2008
March 25, 2010
June 2007
March 2009   (final data collection date for primary outcome measure)
  • Uncorrected Distance Visual Acuity [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Uncorrected Distance Visual Acuity at month 6 measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).
  • Best Corrected Distance Visual Acuity [ Time Frame: 6 Months ] [ Designated as safety issue: No ]
    Best Corrected Distance Visual Acuity at month 6 measured in LogMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).
  • Residual Refractive Cylinder [ Time Frame: 6 Month ] [ Designated as safety issue: No ]
    Residual Refractive Cylinder at month 6 measured in diopters (D).
Visual Acuity, Residual Refractive Cylinder [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00732030 on ClinicalTrials.gov Archive Site
Patient Satisfaction Survey [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Satisfaction for daytime distance vision, nighttime distance vision, and indoors distance vision on a scale of 1 to 5, with 1 being very dissatisfied and 5 being very satisfied.
Patient Satisfaction Survey [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Low Cylinder Toric
Evaluation of the Acrysof Toric Model SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.03 Diopters (D)

Study evaluates the visual outcomes and patient satisfaction after implantation of a toric intraocular lens (IOL).

Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Cataracts
Device: Toric IOL (SN60T3)
Each enrolled eye implanted with the AcrySof Toric Model SN60T3 intraocular lens (IOL) for the treatment of cataract.
Experimental: AcrySof Toric T3
Each enrolled eye receives AcrySof Toric Model SN60T3 Intraocular Lens (IOL)
Intervention: Device: Toric IOL (SN60T3)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
26
Not Provided
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed with Cataracts
  • Predicted residual corneal astigmatism between 0.75 and 1.03 Diopters (D)

Exclusion Criteria:

  • Preoperative ocular pathology
  • Planned monovision
Both
21 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00732030
M07-005
No
Rick Potvin/Director - Global Scientific Market Affairs, Alcon Research
Alcon Research
Not Provided
Not Provided
Alcon Research
March 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP